Mankind Pharma has a total of 241 patents globally, out of which 84 have been granted. Of these 241 patents, more than 84% patents are active. India is where Mankind Pharma has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, India seems to be the main focused R&D center of Mankind Pharma and is also the origin country of the firm.
Mankind Pharma was founded in the year 1991 by R. C. Juneja. Company is an Indian pharmaceutical and healthcare products company.
Do read about some of the most popular patents of Mankind Pharma which have been covered by us in this article and also you can find Mankind Pharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Mankind Pharma patent portfolio.
How many patents does Mankind Pharma have?
Mankind Pharma has a total of 241 patents globally. These patents belong to 156 unique patent families. Out of 241 patents, 204 patents are active.
How Many Patents did Mankind Pharma File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Mankind Pharma Applications Filed | Mankind Pharma Patents Granted |
2022 | 13 | 27 |
2021 | 30 | 15 |
2020 | 52 | 10 |
2019 | 31 | 13 |
2018 | 29 | 5 |
2017 | 54 | 1 |
2016 | 6 | 2 |
2015 | 5 | – |
2014 | 5 | – |
2013 | 7 | 1 |
2012 | 4 | – |
2011 | 2 | 2 |
Explore the top-performing drugs that dominate the Pharmaceutical Industry
Patent Number | Company | Product | Brand | Revenue | Patent Expiry Date |
US9174975 | Sumitomo Pharma | Lurasidone Hydrochloride | Latuda | $1.75B | Jun-26 |
US7612199 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
US7902206 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
US8158644 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
US7371727 | Ironwood Pharma | Linaclotide | Linzess | $1.00B | Mar-25 |
Want to know which drugs are making over $1 Billion annually?
How many Mankind Pharma patents are Alive/Dead?
Worldwide Patents
How Many Patents did Mankind Pharma File in Different Countries?
Countries in which Mankind Pharma Filed Patents
Country | Patents |
India | 129 |
United States Of America | 24 |
Europe | 8 |
Taiwan | 7 |
South Africa | 6 |
Australia | 6 |
Canada | 5 |
Brazil | 5 |
Mexico | 4 |
New Zealand | 4 |
Germany | 4 |
China | 3 |
Japan | 3 |
Argentina | 3 |
Austria | 2 |
Russia | 2 |
Hong Kong (S.A.R.) | 2 |
Spain | 2 |
Italy | 2 |
Where are Research Centres of Mankind Pharma Patents Located?
10 Best Mankind Pharma Patents
IN202011029286A is the most popular patent in the Mankind Pharma portfolio. It has received 7 citations so far from companies like MSN Laboratories.
Below is the list of 10 most cited patents of Mankind Pharma:
Publication Number | Citation Count |
IN202011029286A | 7 |
WO2019073325A1 | 5 |
WO2019073477A1 | 5 |
WO2019008485A1 | 4 |
US10208030B2 | 3 |
US20170217911A1 | 3 |
IN201911046559A | 3 |
IN201811030659A | 3 |
WO2021005484A1 | 2 |
WO2020240586A1 | 2 |
What are Mankind Pharma key innovation segments?
What Technologies are Covered by Mankind Pharma?
The chart below distributes patents filed by Mankind Pharma